How did Elizabeth Holmes' Theranos Scam Come to Be?

Thanks to the new Netflix documentary, the strange and disturbing story of Elizabeth Holmes, founder of biotech company Theranos, has once again become major fodder for discourse and debate. Hailed as "the next Steve Jobs," Holmes rose to prominence around 2013 when her company reached its peak valuation at $100 billion. Theranos was founded in 2003 in the hopes of revolutionizing blood testing, allowing users to analyze their own health using only a single drop of blood with an at-home test. 

The scientific viability of Holmes' plan came into question soon after, with holes beginning to emerge in her claims about what Theranos was capable of. Now Holmes is facing up to twenty years in jail for what amounts to investor fraud. This ABC news podcast, "The Drop Out," takes you through the rise and fall of Holmes and her startup in seven episodes. What's unique about this angle of the story is its focus on the whole legal and scientific apparatus that allowed Holmes to so spectacularly bluff her way into investment, trying to understand not only Holmes as a person and her motives (as many other profiles have done) but the social and professional contexts that provided the possibility for a scam of such global proportions to blossom.